4/24/2013

Lubiprostone has gained widened FDA approval, making it the first oral therapy approved for opioid-linked constipation in adults who have chronic, noncancer pain. The drug was previously approved for chronic idiopathic constipation among adults and constipation associated with irritable bowel syndrome in adult women.

Related Summaries